Addus HomeCare (NASDAQ:ADUS) Lowered to “Hold” Rating by Wall Street Zen

Addus HomeCare (NASDAQ:ADUS) was downgraded by Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued to investors on Saturday.

ADUS has been the subject of several other reports. Stephens reaffirmed an “overweight” rating and set a $142.00 price target on shares of Addus HomeCare in a research note on Wednesday, March 12th. Macquarie reaffirmed an “outperform” rating and set a $133.00 price target on shares of Addus HomeCare in a research note on Tuesday, June 10th. Finally, JMP Securities reissued a “market outperform” rating and issued a $150.00 price objective on shares of Addus HomeCare in a report on Friday. One research analyst has rated the stock with a hold rating, six have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, Addus HomeCare currently has an average rating of “Buy” and a consensus price target of $142.57.

Addus HomeCare Price Performance

NASDAQ ADUS opened at $113.79 on Friday. The stock has a market cap of $2.09 billion, a price-to-earnings ratio of 25.69, a PEG ratio of 1.63 and a beta of 0.81. Addus HomeCare has a 52-week low of $88.96 and a 52-week high of $136.72. The business has a 50 day simple moving average of $108.91 and a 200 day simple moving average of $111.98. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.74 and a current ratio of 1.74.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, topping the consensus estimate of $1.33 by $0.09. The company had revenue of $337.71 million during the quarter, compared to analysts’ expectations of $341.66 million. Addus HomeCare had a net margin of 6.52% and a return on equity of 9.23%. The business’s quarterly revenue was up 20.3% on a year-over-year basis. During the same period last year, the business earned $1.21 EPS. Analysts anticipate that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

Insider Activity

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 2,045 shares of the firm’s stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total transaction of $235,175.00. Following the completion of the sale, the executive vice president now owns 7,796 shares of the company’s stock, valued at $896,540. This trade represents a 20.78% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 4.60% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Addus HomeCare

Hedge funds have recently added to or reduced their stakes in the business. Natixis lifted its holdings in Addus HomeCare by 111.9% during the 4th quarter. Natixis now owns 250 shares of the company’s stock valued at $31,000 after purchasing an additional 132 shares during the last quarter. Smartleaf Asset Management LLC lifted its holdings in Addus HomeCare by 324.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock valued at $35,000 after purchasing an additional 214 shares during the last quarter. BI Asset Management Fondsmaeglerselskab A S acquired a new stake in Addus HomeCare during the 1st quarter valued at $41,000. Parkside Financial Bank & Trust lifted its holdings in Addus HomeCare by 38.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock valued at $67,000 after purchasing an additional 148 shares during the last quarter. Finally, Meeder Asset Management Inc. acquired a new stake in Addus HomeCare during the 4th quarter valued at $77,000. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.